Real-Life Outcomes of Ponatinib Treatment in Patients with Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph plus ALL): Data from a Nationwide Belgian Registry

被引：3

作者：

Devos, Timothy ^{[1
,2
]}

Havelange, Violaine ^{[3
]}

Theunissen, Koen ^{[4
]}

Meers, Stef ^{[5
]}

Benghiat, Fleur Samantha ^{[6
]}

Gadisseur, Alain ^{[7
]}

Vanstraelen, Gaetan ^{[8
]}

Andre, Marc ^{[9
]}

Bailly, Benjamin ^{[10
]}

Granacher, Nikki ^{[11
]}

Lewalle, Philippe ^{[12
]}

De Becker, Ann ^{[13
]}

Van Eygen, Koen ^{[14
]}

Lejeune, Marie ^{[15
]}

Deeren, Dries ^{[16
]}

Nifosi, Gianfilippo ^{[17
]}

Triffet, Agnes ^{[18
]}

Vrelust, Inge ^{[19
]}

Bekaert, Julie ^{[20
]}

Beck, Michael ^{[21
]}

Selleslag, Dominik ^{[22
]}

机构：

[1] Univ Hosp Leuven, Dept Hematol, Leuven, Belgium

[2] Katholieke Univ Leuven, Dept Microbiol & Immunol, Lab Expt Transplantat, Leuven, Belgium

[3] Clin Univ St Luc, Brussels, Belgium

[4] Jessa Ziekenhuis, Hasselt, Belgium

[5] Algemeen Ziekenhuis Klina, Brasschaat, Belgium

[6] Hop Erasme, Brussels, Belgium

[7] Univ Hosp Antwerp, Edegem, Belgium

[8] Ctr Hosp Pelzer Tourelle, Verviers, Belgium

[9] CHU UCL Namur Site Godinne, Dept Hematol, Yvoir, Belgium

[10] Hop Jolimont, Haine St Paul, Belgium

[11] Ziekenhuis Netwerk Antwerpen Stuivenberg, Antwerp, Belgium

[12] Univ Libre Bruxelles, Inst Jules Bordet, Brussels, Belgium

[13] Univ Ziekenhuis Brussel, Jette, Belgium

[14] Algemeen Ziekenhuis Groeninge, Kortrijk, Belgium

[15] Ctr Hosp Univ Liege Sart Tilman, Liege, Belgium

[16] Algemeen Ziekenhuis Delta, Roeselare, Belgium

[17] Ctr Hosp Univ Brugmann, Brussels, Belgium

[18] Ctr Hosp Univ Charleroi Vesale, Charleroi, Belgium

[19] Algemeen Ziekenhuis Sint Elisabeth, Turnhout, Belgium

[20] Incyte Biosci Int Sarl, Lausanne, Switzerland

[21] Incyte Biosci Benelux BV, Amsterdam, Netherlands

[22] Algemeen Ziekenhuis Sint Jan Brugge, Brugge, Belgium

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-127923

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4161

引用

页数：4

共 50 条

[31] Discontinuation of Tyrosine Kinase Inhibitors (TKIs) in Philadelphia Chromosome-Positive (Ph plus ) Acute Lymphoblastic Leukemia (ALL)
Samra, Bachar
Kantarjian, Hagop M.
Sasaki, Koji
Konopleva, Marina Y.
Khouri, Rita
O'Brien, Susan M.
Ferrajoli, Alessandra
Nunez, Cesar
Kadia, Tapan M.
Jabbour, Elias
BLOOD, 2019, 134
[32] A Phase 1/2 Study to Evaluate the Safety and Efficacy of Ponatinib with Chemotherapy in Pediatric Patients with Philadelphia Chromosome-Positive (Ph plus ) Acute Lymphoblastic Leukemia (ALL)
Matloub, Yousif
Gore, Lia
Loh, Mignon L.
Pui, Chin-Hon
Hanley, Michael J.
Lu, Vickie
Leonard, E. Jane
Granier, Muriel
Biondi, Andrea
Silverman, Lewis B.
BLOOD, 2020, 136
[33] Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives (vol 8, pg 1, 2018)
Anagnostou, Tt
Litzow, M. R.
BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2018, 8 : 11 - 11
[34] Ponatinib-based therapy in adults with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the real-life OPAL study
Tavitian, Suzanne
Uzunov, Madalina
Berard, Emilie
Bouscary, Didier
Thomas, Xavier
Raffoux, Emmanuel
Leguay, Thibaut
Hernanz, Maria Pilar Gallego
Berceanu, Ana
Lepretre, Stephane
Hicheri, Yosr
Chevallier, Patrice
Bertoli, Sarah
Lheritier, Veronique
Dombret, Herve
Huguet, Francoise
LEUKEMIA & LYMPHOMA, 2020, 61 (09) : 2161 - 2167
[35] Outcomes with inotuzumab ozogamicin (InO) in patients with Philadelphia chromosome-positive (Ph plus ) relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL).
Stock, Wendy
Martinelli, Giovanni
Stelljes, Matthias
DeAngelo, Daniel J.
Gokbuget, Nicola
Advani, Anjali S.
O'Brien, Susan Mary
Liedtke, Michaela
Merchant, Akil Abid
Cassaday, Ryan Daniel
Wang, Tao
Vandendries, Erik
Marks, David I.
Kantarjian, Hagop M.
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[36] A phase II trial of a chemotherapy-free combination of ponatinib and blinatumomab in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL).
Short, Nicholas James
Kantarjian, Hagop M.
Konopleva, Marina
Bravo, Guillermo Montalban
Ravandi, Farhad
Jain, Nitin
Kadia, Tapan M.
Valero, Yesid Alvarado
Chien, Kelly Sharon
Daver, Naval Guastad
Macaron, Walid
Sasaki, Koji
Thankachan, Jennifer
Delumpa, Ricardo
Mayor, Ejiroghene
Deen, Wuliamatu
Loiselle, Christopher
Kwari, Monica
Garris, Rebecca
Jabbour, Elias
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[37] Effect of Prophylactic Post-transplant Ponatinib Administration on Outcomes in Patients With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
Nanno, Satoru
Matsumoto, Kana
Nakamae, Mika
Okamura, Hiroshi
Nishimoto, Mitsutaka
Hirose, Asao
Koh, Hideo
Nakashima, Yasuhiro
Nakane, Takahiko
Morita, Kunihiko
Hino, Masayuki
Nakamae, Hirohisa
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (12): : 813 - +
[38] Sprycel for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to or intolerant of imatinib mesylate
Brave, Michael
Goodman, Vicki
Kaminskas, Edvardas
Farrell, Ann
Timmer, William
Pope, Sarah
Harapanhalli, Ravi
Saber, Haleh
Morse, David
Bullock, Julie
Men, Angela
Noory, Carol
Ramchandani, Roshni
Kenna, Leslie
Booth, Brian
Gobburu, Joga
Jiang, Xiaoping
Sridhara, Rajeshwari
Justice, Robert
Pazdur, Richard
CLINICAL CANCER RESEARCH, 2008, 14 (02) : 352 - 359
[39] Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL)
Ottmann, Oliver G.
Wassmann, Barbara
Pfeifer, Heike
Giagounidis, Aristoteles
Stelljes, Matthias
Duehrsen, Ulrich
Schmalzing, Marc
Wunderle, Lydia
Binckebanck, Anja
Hoelzer, Dieter
CANCER, 2007, 109 (10) : 2068 - 2076
[40] Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib
Sasaki, Yuya
Kantarjian, Hagop M.
Short, Nicholas J.
Wang, Feng
Furudate, Ken
Uryu, Hidetaka
Garris, Rebecca
Jain, Nitin
Sasaki, Koji
Ravandi, Farhad
Konopleva, Marina
Garcia-Manero, Guillermo
Little, Latasha
Gumbs, Curtis
Zhao, Li
Futreal, P. Andrew
Takahashi, Koichi
Jabbour, Elias
LEUKEMIA, 2022, 36 (05) : 1253 - 1260

← 1 2 3 4 5 →